Opinion - (2025) Volume 12, Issue 2
Received: 01-Apr-2025, Manuscript No. jpd-26-183903;
Editor assigned: 03-Apr-2025, Pre QC No. P-183903;
Reviewed: 17-Apr-2025, QC No. Q-183903;
Revised: 22-Apr-2025, Manuscript No. R-183903;
Published:
29-Apr-2025
, DOI: 10.37421/2684-4281.2025.12.512
Citation: Kulkarni, Priya N.. ”Acne Vulgaris: Molecular Mechanisms and Targeted Therapies.” J Dermatol Dis 12 (2025):512.
Copyright: © 2025 Kulkarni N. Priya This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Acne vulgaris represents a complex inflammatory dermatological condition, characterized by a pathogenesis deeply intertwined with the interplay of sebaceous gland activity, follicular keratinization processes, the presence of Cutibacterium acnes, and host immune responses. Recent scientific endeavors have illuminated the intricate molecular mechanisms that orchestrate this complex process, including the dysregulation of androgenic hormones, the pivotal role of Toll-like receptor 2 (TLR2) signaling initiated by C. acnes, and the subtle yet significant influence of microRNAs on inflammatory cascades and sebum production dynamics. A comprehensive understanding of these underlying molecular principles is therefore paramount for the development of more precise and efficacious therapeutic strategies aimed at managing acne vulgaris. [1] Further investigation into this prevalent dermatological ailment has specifically delved into the nuanced role played by distinct Cutibacterium acnes strains and their associated virulence factors in initiating and perpetuating the inflammatory cascade characteristic of acne. This research has successfully identified how particular phylotypes of C. acnes elicit a more pronounced and robust immune response, primarily through the activation of TLR2. This activation subsequently leads to an elevated production of pro-inflammatory cytokines, which are recognized as key drivers in the pathogenesis of acne lesions. This mechanistic insight therefore suggests promising avenues for therapeutic interventions that could effectively modulate C. acnes-host interactions. [2] The contribution of individual host genetics and the intricate composition of the skin microbiome to the overall pathogenesis of acne is also extensively explored, with a particular emphasis on how inherent genetic variations can significantly influence an individual's susceptibility and the ultimate severity of the condition. This comprehensive review examines recent genomic studies that have successfully identified specific loci associated with acne susceptibility. Furthermore, it highlights the burgeoning understanding of how a dysbiotic skin microbiome, extending beyond the direct influence of C. acnes, can profoundly impact the integrity of the skin barrier and the delicate balance of immune homeostasis, thereby presenting novel targets for therapeutic intervention. [3] The intricate hormonal pathways, particularly those involving androgens, which govern sebaceous gland function and critically contribute to the development of acne, are meticulously examined. This analysis scrutinizes how genetic variations within the androgen receptor signaling pathways and the activity of 5α-reductase enzymes can precipitate an increase in sebum production, a factor universally acknowledged as central to acne development. Consequently, the therapeutic implications stemming from the targeted manipulation of these hormonal pathways, exemplified by the use of spironolactone, are thoroughly discussed. [4] The therapeutic landscape for acne vulgaris is undergoing a significant evolution, with an increasing focus on dissecting and targeting the specific molecular pathways implicated in its pathogenesis. This article provides a thorough review of the current treatment modalities available for acne management, while simultaneously exploring the potential of emerging therapies. These emerging treatments encompass a range of approaches, including novel topical agents, sophisticated oral medications, and advanced device-based interventions, all evaluated through the critical lens of their demonstrable impact on the molecular underpinnings of acne. The article also considers the integration of personalized medicine approaches, aiming to tailor treatments to individual patient profiles. [5] In parallel, this study meticulously investigates the crucial role of microRNAs (miRNAs) in the complex pathogenesis of acne. It identifies specific miRNAs that exert regulatory control over both sebaceous gland function and the inflammatory processes involved in acne development. The research further explores how disruptions in miRNA expression patterns can significantly contribute to the formation and progression of acne lesions. Consequently, it suggests that miRNA-based therapeutic strategies hold considerable promise as a novel treatment avenue by effectively modulating gene expression related to sebum production and the inflammatory response. [6] The cellular and molecular mechanisms underlying follicular hyperkeratinization, a key event in the pathogenesis of acne vulgaris, are critically examined, with a specific focus on abnormalities in desquamation processes. The article elaborates on how altered expression patterns of crucial adhesion molecules and factors that regulate keratinocyte differentiation contribute directly to the formation of microcomedones, which represent the earliest pathological lesion in acne. Subsequently, therapies designed to normalize these aberrant keratinization processes are thoughtfully considered. [7] This review offers a detailed examination of the multifaceted inflammatory response that characterizes acne vulgaris, thoroughly delineating the specific roles played by a diverse array of immune cells and signaling mediators. It elucidates how the presence of C. acnes serves as a potent stimulus for keratinocytes and sebocytes, prompting them to generate pro-inflammatory cytokines and chemokines. This inflammatory milieu subsequently facilitates the recruitment of neutrophils and macrophages to the affected skin sites. The therapeutic implications arising from the targeted inhibition of these specific inflammatory pathways are also thoroughly explored, including the significant potential of various anti-inflammatory agents. [8] This paper undertakes an in-depth investigation into the influence of dietary patterns on the pathogenesis of acne vulgaris, focusing specifically on the underlying molecular mechanisms. The research emphasizes the impact of consuming high glycemic index foods and dairy products. It discusses how these specific dietary factors can modulate critical signaling pathways such as the insulin-like growth factor 1 (IGF-1) and mammalian target of rapamycin (mTOR) pathways. These modulations, in turn, can stimulate increased sebum production and enhance keratinocyte proliferation, thereby exacerbating the symptoms and severity of acne. [9] The cellular and molecular mechanisms driving follicular hyperkeratinization in acne vulgaris are a central focus, with particular attention paid to the abnormalities in the desquamation process. This review discusses how altered expression of key adhesion molecules and factors regulating keratinocyte differentiation contribute to the formation of microcomedones, the initial pathological lesion in acne. Therapeutic strategies aimed at normalizing keratinization are considered as potential interventions. [10]
Acne vulgaris, a complex inflammatory skin condition, originates from a multifaceted interplay involving sebaceous gland activity, follicular keratinization, the bacterium Cutibacterium acnes, and the host's immune system. Contemporary research has unveiled intricate molecular pathways driving this process, such as the dysregulation of androgens, the activation of TLR2 signaling by C. acnes, and the regulatory role of microRNAs in inflammation and sebum production. Grasping these molecular underpinnings is essential for devising targeted and effective acne therapies. [1] This research specifically probes the role of distinct Cutibacterium acnes strains and their virulence factors in initiating the inflammatory cascade observed in acne. It identifies how certain C. acnes phylotypes induce a heightened immune response via TLR2 activation, leading to increased production of pro-inflammatory cytokines, a primary driver of acne lesions. This mechanistic understanding paves the way for therapies that could modulate C. acnes-host interactions. [2] The influence of host genetics and the skin microbiome on acne pathogenesis is explored, highlighting how individual genetic variations can affect susceptibility and severity. This review discusses recent genomic findings identifying susceptibility loci and emphasizes the emerging understanding of how a dysbiotic skin microbiome, beyond C. acnes, impacts the skin barrier and immune homeostasis, offering new therapeutic targets. [3] This article delves into the intricate hormonal pathways, particularly androgens, that regulate sebaceous gland function and contribute to acne development. It examines how genetic variations in androgen receptor signaling and 5α-reductase activity can lead to increased sebum production, a crucial factor in acne formation. The therapeutic potential of targeting these pathways, such as with spironolactone, is discussed. [4] The therapeutic landscape for acne vulgaris is rapidly evolving, with a growing emphasis on understanding and targeting the underlying molecular pathways. This article reviews current treatment modalities and explores emerging therapies, including topical agents, oral medications, and device-based treatments, evaluated based on their impact on acne's molecular pathogenesis. The integration of personalized medicine is also considered. [5] This study investigates the role of microRNAs (miRNAs) in acne pathogenesis, identifying specific miRNAs that regulate sebaceous gland function and inflammation. It explores how altered miRNA expression can contribute to acne lesion development and suggests that miRNA-based therapies might offer a new treatment avenue by modulating gene expression related to sebum production and inflammation. [6] The cellular and molecular mechanisms of follicular hyperkeratinization in acne vulgaris are examined, focusing on desquamation abnormalities. It discusses how altered expression of adhesion molecules and keratinocyte differentiation factors contribute to the formation of microcomedones, the initial lesion in acne. Therapies aimed at normalizing keratinization are considered. [7] This review details the multifaceted inflammatory response in acne, outlining the roles of various immune cells and mediators. It explains how C. acnes stimulates keratinocytes and sebocytes to produce pro-inflammatory cytokines and chemokines, attracting neutrophils and macrophages. The therapeutic implications of targeting these specific inflammatory pathways are explored, including the potential of anti-inflammatory agents. [8] This paper investigates the molecular mechanisms by which diet influences acne pathogenesis, focusing on the impact of high glycemic index foods and dairy products. It discusses how these dietary factors can modulate insulin-like growth factor 1 (IGF-1) and mTOR signaling pathways, which subsequently stimulate sebum production and keratinocyte proliferation, thereby worsening acne. [9] The therapeutic approaches for acne vulgaris are continuously advancing, driven by a deeper understanding of its molecular pathogenesis. This article reviews existing treatments and examines novel therapies, including topical, oral, and device-based interventions, assessing their efficacy in light of molecular mechanisms. The potential of personalized medicine in acne treatment is also explored. [10]
Acne vulgaris is a complex inflammatory skin condition driven by multiple factors including sebaceous gland activity, follicular keratinization, Cutibacterium acnes, and immune responses. Recent research highlights molecular mechanisms such as androgen dysregulation, TLR2 signaling by C. acnes, and the influence of microRNAs on inflammation and sebum production. Understanding these pathways is crucial for developing targeted therapies. Specific C. acnes strains and their virulence factors play a role in inflammation. Host genetics and the skin microbiome also contribute to acne susceptibility and severity. Hormonal pathways involving androgens are key regulators of sebaceous glands. Emerging therapies focus on modulating inflammatory pathways, while microRNAs offer new therapeutic targets by regulating gene expression. Follicular hyperkeratinization and desquamation abnormalities are central to lesion formation. The inflammatory milieu involves various immune cells and mediators. Dietary factors like high glycemic index foods and dairy can exacerbate acne by influencing IGF-1 and mTOR signaling. Current and emerging treatments aim to address these molecular underpinnings.
None
None
Journal of Dermatology and Dermatologic Diseases received 4 citations as per Google Scholar report
